Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Zogenix, Inc. (ZGNX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.14+0.23 (+1.78%)
At close: 04:00PM EST
13.14 0.00 (0.00%)
After hours: 05:39PM EST
Advertisement
Sign in to post a message.
  • J
    JD
    Hopefully, we get some consolidation above 13.00. Closing a weekly near $15 will be key.
  • S
    SAN
    This can touch $23 in short range.
  • S
    SAN
    This is dirt cheap, so grab this one before it jumps..
  • P
    Park
    Any reasons why this is down 70% in a year? Looking to open a position. What catalysts are in the next few qtrs? Thx guys
  • A
    Audiophulle
    I own a very good Biotech that is so good that it pays a constant dividend and has many growth prospects... in other words, it's a safer stock than this speculative #$%$ which has only disappointed investors over the past decade.
  • J
    JD
    Have we found the base? If not, should be close based on 2017 support level.
  • 💊C
  • f
    fred
    I hold 10 shares because I am a true believer. :)
  • 💊C
    First time in years we haven’t taken a big hit after earnings. Priority Review for LGS coming, then we’ll push past $20. We’re almost there!
  • P
    Percy21
    Encouraged by today's runnup ahead of earnings release.
  • A
    Audiophulle
    To David... this is still a waste of money vs other stocks you could have wasted your time on.

    ZGNX is run by failed management... always has been.
  • Y
    Yahoo Finance Insights
    Zogenix is up 5.49% to 12.50
  • c
    cd
    5 years and this is up only 10%.
  • S
    SAN
    As always, the sp faded towards the end of the session, back to 15.99. What are the odds that it closed at 15.99? As expected, it goes up in the green AH. No wonder, it will be back in the red again tomorrow. Everything is so predictable...
  • k
    killer klown
    Is this board alive or dead..................seems dead and that's a shame. Well anyway we had good news today although market timing sucks, but this stock is in a world of it's own. While the label was and is an issue, over time and with testing this is not a redo of the distant past diet pill (fen-phen) some two decades ago. Well time will tell with usage #'s (early Nov. 3rd qtr CC) if we continue to see growth? are people going to start getting on the train. I suggest one goes to the web site, although a layman I see far more diligence regarding care and testing than just a cursory talk to your doctor.
    Bullish
  • 💊C
    LGS OLE 🎯 here we go!
    Bullish
  • S
    SAN
    So market was up yesterday and today significantly. This was, as usual, in red yesterday and also today it down. I am sure there are lots of smart people here, ever think why this is so? Not to mention, on a weak market, this was in green. Distinctive red on an up market for two consecutive days... expect the unexpected... is the norm for this one.. GLTA..!
  • 💊C
    Who’s ready for LGS Priority Review to blow this thing thru the roof?!
    Bullish
  • H
    Hervelo
    Beautiful day and volume !
  • D
    David
    Mizuho Securities’ Difei Yang also reiterated her bullish perspective on the stock saying “We note that this is a broader patient designation than the Phase 3 trial, which consisted of subjects age 2-18.” The analyst points out that the labeling includes a boxed warning which states that Fintepla is associated with valvular heart disease (VHD) and pulmonary arterial hypertension (PAH)- but says that this is also ‘as expected’.

    Yang already had a 100% probability of success on the indication and so reaffirmed her buy rating and $64 price target. This suggests shares can more than double from current levels.
    Bullish
Advertisement
Advertisement